Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials.

Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, Carrozza JP Jr, Chauhan MS, Rodriguez O, Kuntz RE.

Circulation. 2001 Apr 17;103(15):1967-71.

2.
3.

Wiktor stent for treatment of chronic total coronary artery occlusions: short- and long-term clinical and angiographic results from a large multicenter experience.

Anzuini A, Rosanio S, Legrand V, Tocchi M, Coppi R, Bonnier H, Sheiban I, Kulbertus HE, Chierchia SL.

J Am Coll Cardiol. 1998 Feb;31(2):281-8.

4.

[Subacute thrombosis with antiplatelet treatment in a non-selected population of intracoronary stents: incidence and predictors].

Pascual Figal DA, Valdés Chávarri M, Ruipérez JA, Cortés R, López Pálop R, Picó Aracil F, García Alberola A.

Rev Esp Cardiol. 2000 Jun;53(6):791-6. Spanish.

5.
6.

Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.

Rinaldi MJ, Kirtane AJ, Piana RN, Caputo RP, Gordon PC, Lopez JJ, Dauerman HL, Ryan TJ Jr, Kiernan FJ, Cutlip DE, Ho KK, Gibson CM, Murphy SA, Cohen DJ.

Am Heart J. 2008 Apr;155(4):654-60. doi: 10.1016/j.ahj.2007.11.028. Epub 2008 Feb 21.

PMID:
18371472
7.

High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation.

Nakamura S, Hall P, Gaglione A, Tiecco F, Di Maggio M, Maiello L, Martini G, Colombo A.

J Am Coll Cardiol. 1997 Jan;29(1):21-7.

8.

Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry.

Orford JL, Lennon R, Melby S, Fasseas P, Bell MR, Rihal CS, Holmes DR, Berger PB.

J Am Coll Cardiol. 2002 Nov 6;40(9):1567-72.

9.

Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management.

Lablanche JM, McFadden EP, Bonnet JL, Grollier G, Danchin N, Bedossa M, Leclercq C, Vahanian A, Bauters C, Van Belle E, Bertrand ME.

Eur Heart J. 1996 Sep;17(9):1373-80.

10.

A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents.

Mueller C, Roskamm H, Neumann FJ, Hunziker P, Marsch S, Perruchoud A, Buettner HJ.

J Am Coll Cardiol. 2003 Mar 19;41(6):969-73.

11.

Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.

Bartorelli AL, Tamburino C, Trabattoni D, Galassi A, Serdoz R, Sheiban I, Piovaccari G, Zimarino M, Benassi A, Di Mario C, Sangiorgio P, Chierchia S, Reimers B; Sorin Group.

Am J Cardiol. 2007 Apr 15;99(8):1062-6. Epub 2007 Mar 5.

PMID:
17437728
13.

Antiplatelet therapy alone is safe and effective after coronary stenting: observations of a transition in practice.

Zubaid M, Penn IM, Buller CE, Moscovich MD, Ricci DR, Chauhan A.

Can J Cardiol. 1997 Apr;13(4):335-40.

PMID:
9141964
14.

Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registry.

Cutlip DE, Leon MB, Ho KK, Gordon PC, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Fitzpatrick MM, Desjardin A, Popma JJ, Kuntz RE, Baim DS.

J Am Coll Cardiol. 1999 Sep;34(3):698-706.

15.

Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.

Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL; SPIRIT III Investigators.

Circulation. 2009 Feb 10;119(5):680-6. doi: 10.1161/CIRCULATIONAHA.108.803528. Epub 2009 Jan 26.

16.

Rationale for low-molecular weight heparin in coronary stenting.

Zidar JP.

Am Heart J. 1997 Nov;134(5 Pt 2):S81-7. Review.

PMID:
9396639
17.

A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation.

Hall P, Nakamura S, Maiello L, Itoh A, Blengino S, Martini G, Ferraro M, Colombo A.

Circulation. 1996 Jan 15;93(2):215-22.

18.

Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS).

Urban P, Macaya C, Rupprecht HJ, Kiemeneij F, Emanuelsson H, Fontanelli A, Pieper M, Wesseling T, Sagnard L.

Circulation. 1998 Nov 17;98(20):2126-32.

19.

Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting.

Bhatt DL, Bertrand ME, Berger PB, L'Allier PL, Moussa I, Moses JW, Dangas G, Taniuchi M, Lasala JM, Holmes DR, Ellis SG, Topol EJ.

J Am Coll Cardiol. 2002 Jan 2;39(1):9-14.

20.

Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study.

Byrne RA, Schulz S, Mehilli J, Iijima R, Massberg S, Neumann FJ, ten Berg JM, Schömig A, Kastrati A; Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) Investigators.

Am Heart J. 2009 Apr;157(4):620-4.e2. doi: 10.1016/j.ahj.2008.12.019.

PMID:
19332187
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk